Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review (Q37975889)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 January 2012

Language	Label	Description	Also known as
English	Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review	scientific article published on 11 January 2012

Statements

scholarly article

1 reference

Europe PubMed Central

26 August 2017

Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review (English)

1 reference

Europe PubMed Central

26 August 2017

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

endometrial hyperplasia

1 reference

based on heuristic

inferred from title

author name string

Camille C Gunderson

1

1 reference

Europe PubMed Central

26 August 2017

Amanda Nickles Fader

2

1 reference

Europe PubMed Central

26 August 2017

Kathryn A Carson

3

1 reference

Europe PubMed Central

26 August 2017

Robert E Bristow

4

1 reference

Europe PubMed Central

26 August 2017

language of work or name

0 references

publication date

11 January 2012

1 reference

Europe PubMed Central

26 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

26 August 2017

125

1 reference

Europe PubMed Central

26 August 2017

2

1 reference

Europe PubMed Central

26 August 2017

477-482

1 reference

Europe PubMed Central

26 August 2017

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Efficacy of megestrol acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Progestogen treatment options for early endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Successful twin pregnancy achieved by assisted reproductive technology in a patient with polycystic ovary syndrome with complex atypical endometrial hyperplasia treated with levonorgestrel-releasing intrauterine system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Two successful pregnancies after in vitro fertilization and embryo transfer in a patient with endometrial atypical hyperplasia bordering on adenocarcinoma treated conservatively with high-dose progesterone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

ICSI outcome following conservative fertility sparing management of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Outcome of fertility-preserving treatment in young women with endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Successful pregnancy following insertion of a levonorgestrel-releasing intrauterine system in two infertile patients with complex atypical endometrial hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Pregnancy following intracytoplasmic sperm injection and preimplantation genetic diagnosis after the conservative management of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Malignant transformation of atypical endometrial hyperplasia after progesterone therapy showing germ-cell tumor-like differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

A successful live birth through in vitro fertilization program after conservative treatment of FIGO grade I endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Case report: Successful IVF programme after conservatively treated endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Preserving fertility before assisted reproduction in women with endometrial carcinoma: case report and literature review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Conservative therapy of stage I endometrial adenocarcinoma and atypical endometrial hyperplasia for the preservation of fertility

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Successful pregnancies in 2 infertile patients with endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Levonorgestrel-releasing intrauterine system alone as primary treatment in young women with early endometrial cancer: case report

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

A patient with stage 1a endometrial carcinoma in whom a solitary recurrent lesion was detected in the external iliac lymph node after MPA therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Frequency and characteristics of endometrial carcinoma and atypical hyperplasia detected on routine infertility investigations in young women: a report of six cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

A rare case of choroidal metastasis presented after conservative management of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Long-term conservative therapy for endometrial adenocarcinoma in young women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Outcomes of conservative therapy for young women with early endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Progestational agents in the treatment of carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Intrauterine progesterone treatment of early endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Coexisting ovarian malignancy in young women with endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.003

7 January 2021

Identifiers

10.1016/J.YGYNO.2012.01.003

1 reference

Europe PubMed Central

26 August 2017

1 reference

Europe PubMed Central

26 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37975889&oldid=2097575270"